echoloc

BIOCODEX Tech Stack

Global pharmaceutical manufacturer focused on microbiota, women's health, and orphan diseases

Pharmaceutical Manufacturing Gentilly, Île-de-France 1,001–5,000 employees Founded 1953 Privately Held

Biocodex is a Paris-based pharmaceutical manufacturer with €500M+ in annual revenue, operating across 100+ countries through owned subsidiaries and distributor networks. The company is mid-implementation on a major SAP rollout while managing three distinct therapeutic franchises—microbiota care, women's health, and orphan diseases—each with different regulatory, commercial, and supply-chain demands. Hiring velocity is accelerating across marketing, sales, and finance, suggesting expansion of commercial infrastructure and a push toward standardized reporting (OneStream adoption alongside SAP signals a shift toward centralized financial planning).

Tech Stack 35 technologies

Core StackMySQL PHP GitLab JavaScript jQuery WordPress Laravel Vue Cloudflare Jira SAP AWS Adobe Creative Cloud Canva Veeva Talkwalker Pinterest Apache Debian HTML5 Bash Symfony Eudravigilance VBA Amazon Advertising IQVIA Bing Google Analytics 4 OneStream Onestream+4 more
AdoptingSAP

What BIOCODEX Is Building

Challenges

  • Ensuring tax compliance
  • Hris data reliability
  • Business expansion
  • Expanding regional presence
  • Controlling opex spending
  • Improving event measurement
  • Reduced yield
  • Supply chain issues
  • In-store compliance
  • Aligning bd opportunities with strategy

Active Projects

  • Sap implementation
  • Online campaign deployment
  • Regional community engagement strategy
  • Hr performance campaign
  • Newsletters
  • Negotiating in/out-licensing deals
  • Product acquisitions and m&as
  • Client risk management deployment
  • Salary review campaign
  • Continuous improvement of reporting processes

Hiring Activity

Accelerating65 roles · 40 in 30d

Department

Marketing
14
Sales
11
Finance
6
Healthcare
5
Ops
5
HR
4
Research
4
Legal
3

Seniority

Intern
25
Mid
20
Manager
7
Senior
7
Junior
6
Director
2

Notable leadership hires: Business Development Director, Product Training Lead

Company intelligence

Find more companies like BIOCODEX by tech stack, pain points and active projects

Get started free

About BIOCODEX

Biocodex develops and markets pharmaceutical products originating from its flagship probiotic yeast strain, Saccharomyces boulardii CNCM I-745®, discovered in 1953. The company operates in gastroenterology, neurology, pain management, pediatrics, rheumatology, otolaryngology, women's health, and orphan disease segments. With 1,700+ employees, Biocodex generates two-thirds of revenue internationally, with presence across 16 wholly owned subsidiaries and a global distributor network. The organization is actively managing product licensing, M&A activity, and regional expansion while addressing supply-chain and yield-management challenges.

HeadquartersGentilly, Île-de-France
Company Size1,001–5,000 employees
Founded1953
Hiring MarketsVietnam, Ukraine, France, Morocco, United States, Romania, Poland, Portugal

Frequently Asked Questions

What is Biocodex's primary therapeutic focus?

Biocodex operates in three main areas: microbiota care (built on its proprietary probiotic yeast strain), women's health, and orphan diseases. Additional specialties span gastroenterology, neurology, pain management, pediatrics, and rheumatology.

Where does Biocodex hire internationally?

Biocodex posts roles across nine countries: Vietnam, Ukraine, France, Morocco, the United States, Romania, Poland, Portugal, and Turkey. Marketing and sales roles represent the largest hiring categories.

What enterprise software is Biocodex implementing?

Biocodex is actively implementing SAP as a core ERP system. The company also uses OneStream for financial planning and Veeva for life-sciences compliance and medical affairs management.

How this profile is built

BIOCODEX's technology stack, projects, and hiring signals are inferred from public hiring and company data — career pages, public listings, and company web presence — then clustered and de-duplicated. Figures are estimates that refresh over time. Read our full methodology →

This is not an official vendor or customer list. It is a technology-adoption signal inferred from public data, intended for B2B research.